Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0028754 (
obesity
)
124,988
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recent studies have shown that SNPs in the
FTO
gene predispose to childhood and adult
obesity
. In this study, we examined the association between variants in
FTO
and KIAA1005, a gene that maps closely to
FTO
, and
obesity
, as well as
obesity
related traits among 450 well characterised severely obese children and 512 normal weight controls.
FTO
showed significant association with several
obesity
related traits while SNPs in KIAA1005 did not. When stratified by gender, the
FTO
variant rs9939609 showed association with
obesity
and BMI among girls (P=0.006 and 0.004, respectively) but not among boys. Gender differences were also found in the associations of the
FTO
rs9939609 with
obesity
related traits such as insulin sensitivity and plasma glucose. This study suggests that
FTO
may have an important role for gender specific development of severe
obesity
and insulin resistance in children.
...
PMID:Major gender difference in association of FTO gene variant among severely obese children with obesity and obesity related phenotypes. 1824 88
Two recent, large whole-genome association studies (GWAS) in European populations have associated a approximately 47-kb region that contains part of the
FTO
gene with high body mass index (BMI). The functions of
FTO
and adjacent FTM in human biology are not clear. We examined expression of these genes in organs of mice segregating for monogenic
obesity
mutations, exposed to underfeeding/overfeeding, and to 4 degrees C. Fto/Ftm expression was reduced in mesenteric adipose tissue of mice segregating for the Ay, Lep ob, Lepr db, Cpe fat, or tub mutations, and there was a similar trend in other tissues. These effects were not due to adiposity per se. Hypothalamic Fto and Ftm expression were decreased by fasting in lean and obese animals and by cold exposure in lean mice. The fact that responses of Fto and Ftm expression to these manipulations were almost indistinguishable suggested that the genes might be coregulated. The putative overlapping regulatory region contains at least two canonical CUTL1 binding sites. One of these nominal CUTL1 sites includes rs8050136, a SNP associated with high body mass. The A allele of rs8050136 preferentially bound CUTL1[corrected] in human fibroblast DNA. 70% knockdown of CUTL1 expression in human fibroblasts decreased
FTO
and FTM expression by 90 and 65%, respectively. Animals and humans with various genetic interruptions of
FTO
or FTM have phenotypes reminiscent of aspects of the Bardet-Biedl
obesity
syndrome, a confirmed "ciliopathy." FTM has recently been shown to be a ciliary basal body protein.
...
PMID:Regulation of Fto/Ftm gene expression in mice and humans. 1825 37
Obesity
is a major public health problem with strong genetic determination; however, the genetic factors underlying
obesity
are largely unknown. In this study, we performed a genome-wide association scan for
obesity
by examining approximately 500 000 single-nucleotide polymorphisms (SNPs) in a sample of 1000 unrelated US Caucasians. We identified a novel gene, CTNNBL1, which has multiple SNPs associated with body mass index (BMI) and fat mass. The most significant SNP, rs6013029, achieved experiment-wise P-values of 2.69 x 10(-7) for BMI and of 4.99 x 10(-8) for fat mass, respectively. The SNP rs6013029 minor allele T confers an average increase in BMI and fat mass of 2.67 kg/m(2) and 5.96 kg, respectively, compared with the alternative allele G. We further genotyped the five most significant CTNNBL1 SNPs in a French case-control sample comprising 896 class III obese adults (BMI > or = 40 kg/m(2)) and 2916 lean adults (BMI < 25 kg/m(2)). All five SNPs showed consistent associations with
obesity
(8.83 x 10(-3) < P < 6.96 x 10(-4)). Those subjects who were homozygous for the rs6013029 T allele had 1.42-fold increased odds of
obesity
compared with those without the T allele. The protein structure of CTNNBL1 is homologous to beta-catenin, a family of proteins containing armadillo repeats, suggesting similar biological functions. beta-Catenin is involved in the Wnt/beta-catenin-signaling pathway which appears to contribute to maintaining the undifferentiated state of pre-adipocytes by inhibiting adipogenic gene expression. Our study hence suggests a novel mechanism for the development of
obesity
, where CTNNBL1 may play an important role. Our study also provided supportive evidence for previously identified associations between
obesity
and INSIG2 and PFKP, but not
FTO
.
...
PMID:Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. 1832 10
Recently an association was demonstrated between the single nucleotide polymorphism (SNP), rs9939609, within the
FTO
locus and
obesity
as a consequence of a genome wide association (GWA) study of type 2 diabetes in adults. We examined the effects of two perfect surrogates for this SNP plus 11 other SNPs at this locus with respect to our childhood
obesity
cohort, consisting of both Caucasians and African Americans (AA). Utilizing data from our ongoing GWA study in our cohort of 418 Caucasian obese children (BMI>or=95th percentile), 2,270 Caucasian controls (BMI<95th percentile), 578 AA obese children and 1,424 AA controls, we investigated the association of the previously reported variation at the
FTO
locus with the childhood form of this disease in both ethnicities. The minor allele frequencies (MAF) of rs8050136 and rs3751812 (perfect surrogates for rs9939609 i.e. both r(2) = 1) in the Caucasian cases were 0.448 and 0.443 respectively while they were 0.391 and 0.386 in Caucasian controls respectively, yielding for both an odds ratio (OR) of 1.27 (95% CI 1.08-1.47; P = 0.0022). Furthermore, the MAFs of rs8050136 and rs3751812 in the AA cases were 0.449 and 0.115 respectively while they were 0.436 and 0.090 in AA controls respectively, yielding an OR of 1.05 (95% CI 0.91-1.21; P = 0.49) and of 1.31 (95% CI 1.050-1.643; P = 0.017) respectively. Investigating all 13 SNPs present on the Illumina HumanHap550 BeadChip in this region of linkage disequilibrium, rs3751812 was the only SNP conferring significant risk in AA. We have therefore replicated and refined the association in an AA cohort and distilled a tag-SNP, rs3751812, which captures the ancestral origin of the actual mutation. As such, variants in the
FTO
gene confer a similar magnitude of risk of
obesity
to children as to their adult counterparts and appear to have a global impact.
...
PMID:Association analysis of the FTO gene with obesity in children of Caucasian and African ancestry reveals a common tagging SNP. 1833 27
Genome-wide association, the latest gene-finding strategy, has led to the first major success in the field of
obesity
genetics with the discovery of
FTO
(fat mass and obesity associated gene) as an
obesity
-susceptibility gene. A cluster of variants in the first intron of
FTO
showed a strong and highly significant association with
obesity
-related traits in three independent genome-wide association studies, a finding that has been replicated in several other studies including adults and children of European descent. Homozygotes for the risk allele weigh on average 3-4 kg more and have a 1.67-fold increased risk of
obesity
compared with those who did not inherit a risk allele. We are still at an early stage in our understanding of the pathways through which
FTO
confers to increased
obesity
risk. Studies in humans and rodents have suggested a central role for
FTO
through regulation of food intake, whereas others have proposed a peripheral role through an effect on lipolytic activity in adipose tissue. There is no doubt that many more
obesity
-susceptibility loci remain to be discovered. Progress on this front will therefore require major collaborative efforts and pooling of compatible datasets. We stand to learn a lot about the genetic architecture of human
obesity
in the coming years. The expectations are high but many challenges remain. Among the latter, translating new advances into useful guidelines for prevention and treatment of
obesity
will be the most demanding.
...
PMID:FTO: the first gene contributing to common forms of human obesity. 1837 8
To identify common variants influencing body mass index (BMI), we analyzed genome-wide association data from 16,876 individuals of European descent. After previously reported variants in
FTO
, the strongest association signal (rs17782313, P = 2.9 x 10(-6)) mapped 188 kb downstream of MC4R (melanocortin-4 receptor), mutations of which are the leading cause of monogenic severe childhood-onset
obesity
. We confirmed the BMI association in 60,352 adults (per-allele effect = 0.05 Z-score units; P = 2.8 x 10(-15)) and 5,988 children aged 7-11 (0.13 Z-score units; P = 1.5 x 10(-8)). In case-control analyses (n = 10,583), the odds for severe childhood
obesity
reached 1.30 (P = 8.0 x 10(-11)). Furthermore, we observed overtransmission of the risk allele to obese offspring in 660 families (P (pedigree disequilibrium test average; PDT-avg) = 2.4 x 10(-4)). The SNP location and patterns of phenotypic associations are consistent with effects mediated through altered MC4R function. Our findings establish that common variants near MC4R influence fat mass, weight and
obesity
risk at the population level and reinforce the need for large-scale data integration to identify variants influencing continuous biomedical traits.
...
PMID:Common variants near MC4R are associated with fat mass, weight and risk of obesity. 1845 48
The
FTO
gene has significant polymorphic variation associated with
obesity
, but its function is unknown. We screened a population of 150 whites (103F/47M) resident in NE Scotland, United Kingdom, for variants of the
FTO
gene and linked these to phenotypic variation in their energy expenditure (basal metabolic rate (BMR) and maximal oxygen consumption VO(2)max) and energy intake. There was no significant association between the
FTO
genotype and BMR or VO(2)max. The
FTO
genotype was significantly associated (P = 0.024) with variation in energy intake, with average daily intake being 9.0 MJ for the wild-type TT genotype and 10.2 and 9.5 MJ for the "at risk" AT and AA genotypes, respectively. Adjusting intake for BMR did not remove the significance (P = 0.043).
FTO
genotype probably affects
obesity
via effects on food intake rather than energy expenditure.
Obesity
(Silver Spring) 2008 Aug
PMID:Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. 1855 Nov 9
It has been newly reported in recent studies that single-nucleotide polymorphisms (SNPs) in the first intron of the
FTO
gene have been associated with BMI in whites. To determine whether the gene is associated with BMI in Asians also, we performed a replication study of the association of the gene with BMI in a Korean population. Two SNPs in the
FTO
gene (rs1421085 and rs17817449) were genotyped using the TaqMan method in a Korean population (n = 1,733). The two SNPs were then used for an association study with BMI through statistical analyses. The rs1421085 C allele (P = 0.0015, effect size = 0.0056) and rs17817449 G allele (P = 0.0019, effect size = 0.0053) were found to be significantly associated with increased BMI. Our results suggest that
FTO
may be one of the worldwide
obesity
-risk genes.
Obesity
(Silver Spring) 2008 Sep
PMID:Replication of genetic effects of FTO polymorphisms on BMI in a Korean population. 1855 Nov 12
The
FTO
(Fat mass and
obesity
associated) locus has recently been associated with
obesity
and type 2 diabetes (T2D) in humans. To understand the role of the
FTO
gene in polycystic ovary syndrome (PCOS) we genotyped single nucleotide polymorphism (SNP) rs1421085 (C/T) in women with PCOS (n=207) and controls (n=100) from a Central European population. The homozygous C/C genotype showed increased prevalence in PCOS patients either obese or with metabolic syndrome (MetS) compared to lean PCOS patients or controls (27.6%, 38.9%, 22.3%, and 16.3%, respectively). In logistic regression, this genotype strongly associated with MetS (P<0.0001, OR 3.2, 95% CI 1.8-5.7) and impaired fasting glucose (IFG) with P<0.0007, OR 7.7, 95% CI 2.1-28.6, independently of BMI or age, and to AUC(gluc) during OGTT (P<0.0001, alpha=0.99), indicating an influential role of the
FTO
gene in the glucose intolerance component of MetS.
...
PMID:FTO gene associates to metabolic syndrome in women with polycystic ovary syndrome. 1857 14
The human
obesity
susceptibility gene,
FTO
, encodes a protein that is homologous to the DNA repair AlkB protein. The AlkB family proteins utilize iron(II), alpha-ketoglutarate (alpha-KG) and dioxygen to perform oxidative repair of alkylated nucleobases in DNA and RNA. We demonstrate here the oxidative demethylation of 3-methylthymine (3-meT) in single-stranded DNA (ssDNA) and 3-methyluracil (3-meU) in single-stranded RNA (ssRNA) by recombinant human
FTO protein
in vitro. Both human and mouse
FTO
proteins preferentially repair 3-meT in ssDNA over other base lesions tested. They showed negligible activities against 3-meT in double-stranded DNA (dsDNA). In addition, these two proteins can catalyze the demethylation of 3-meU in ssRNA with a slightly higher efficiency over that of 3-meT in ssDNA, suggesting that methylated RNAs are the preferred substrates for
FTO
.
...
PMID:Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO. 1877 98
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>